Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
300435.SZ Stock Summary
Top 10 Correlated ETFs
300435.SZ
In the News
300435.SZ Financial details
Company Rating
Strong Buy
Market Cap
5.22B
Income
285.39M
Revenue
3.32B
Book val./share
7.47
Cash/share
3.56
Dividend
0.1
Dividend %
0.73%
Employees
1.11K
Optionable
No
Shortable
Yes
Earnings
22 Apr 2021
P/E
18.61
Forward P/E
-
PEG
-17.28
P/S
1.57
P/B
1.83
P/C
3.85
P/FCF
-18.63
Quick Ratio
0.77
Current Ratio
1.49
Debt / Equity
0.29
LT Debt / Equity
0.04
-
-
EPS (TTM)
0.58
EPS next Y
-
EPS next Q
-
EPS this Y
12.31%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
22.01%
Revenue last 5Y
40.5%
Revenue Q/Q
9.82%
EPS Q/Q
-
-
-
-
-
SMA20
-3.02%
SMA50
-9.07%
SMA100
3.67%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
10%
ROC
0.11%
Gross Margin
17%
Oper. Margin
11%
Profit Margin
9%
Payout
23%
Shs Outstand
381.38M
Shs Float
171.4M
-
-
-
-
Target Price
-
52W Range
12.96-19.66
52W High
-27.95%
52W Low
+14.08%
RSI
31.97
Rel Volume
0.68
Avg Volume
5.42M
Volume
3.68M
Perf Week
-6.3%
Perf Month
-2.35%
Perf Quarter
-5.39%
Perf Half Y
-7.12%
-
-
-
-
Beta
0.606267
-
-
Volatility
0.3%, 0.42%
Prev Close
0.37%
Price
13.69
Change
0.44%
300435.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 2.37 | 3.87 | 5.24 | 6.38 | 8.55 | |
Net income per share | 0.27 | 0.29 | 0.52 | 0.65 | 0.73 | |
Operating cash flow per share | 0.41 | 0.49 | 1.11 | 0.83 | 0.76 | |
Free cash flow per share | 0.36 | 0.46 | 0.36 | 0.27 | 0.07 | |
Cash per share | 1.04 | 1.37 | 1.98 | 2.51 | 3.37 | |
Book value per share | 3.25 | 7.89 | 6.08 | 6.68 | 7.4 | |
Tangible book value per share | 3.12 | 5.09 | 3.95 | 4.59 | 5.35 | |
Share holders equity per share | 3.25 | 7.89 | 6.08 | 6.68 | 7.4 | |
Interest debt per share | 0.63 | 0.62 | 0.7 | 0.87 | 1.8 | |
Market cap | 2.42B | 2.87B | 4.89B | 8.83B | 5.08B | |
Enterprise value | 2.31B | 2.79B | 4.4B | 8.3B | 4.46B | |
P/E ratio | 35.75 | 37.1 | 24.92 | 36 | 18.27 | |
Price to sales ratio | 4.07 | 2.78 | 2.47 | 3.67 | 1.56 | |
POCF ratio | 23.57 | 22 | 11.65 | 28.04 | 17.62 | |
PFCF ratio | 27.15 | 23.55 | 35.69 | 87.39 | 184.77 | |
P/B Ratio | 2.97 | 1.36 | 2.13 | 3.5 | 1.8 | |
PTB ratio | 2.97 | 1.36 | 2.13 | 3.5 | 1.8 | |
EV to sales | 3.88 | 2.69 | 2.22 | 3.45 | 1.37 | |
Enterprise value over EBITDA | 24.68 | 17.26 | 12.5 | 20.21 | 8.91 | |
EV to operating cash flow | 22.49 | 21.34 | 10.48 | 26.36 | 15.47 | |
EV to free cash flow | 25.92 | 22.84 | 32.11 | 82.14 | 162.22 | |
Earnings yield | 0.03 | 0.03 | 0.04 | 0.03 | 0.05 | |
Free cash flow yield | 0.04 | 0.04 | 0.03 | 0.01 | 0.01 | |
Debt to equity | 0.18 | 0.07 | 0.11 | 0.12 | 0.24 | |
Debt to assets | 0.11 | 0.05 | 0.07 | 0.08 | 0.14 | |
Net debt to EBITDA | -1.18 | -0.54 | -1.4 | -1.29 | -1.24 | |
Current ratio | 1.85 | 1.97 | 1.78 | 1.56 | 1.49 | |
Interest coverage | 7.84 | 14.21 | 29.09 | 24.97 | 15.97 | |
Income quality | 1.52 | 1.69 | 2.17 | 1.28 | 1.04 | |
Dividend Yield | 0.02 | 0.01 | 0.01 | 0 | 0.01 | |
Payout ratio | 0.84 | 0.29 | 0.14 | 0.18 | 0.18 | |
Sales general and administrative to revenue | 0.06 | 0.03 | 0.02 | 0.02 | 0.01 | |
Research and developement to revenue | 0.04 | 0.02 | 0.01 | 0.02 | 0.02 | |
Intangibles to total assets | 0.02 | 0.26 | 0.23 | 0.2 | 0.17 | |
Capex to operating cash flow | -0.13 | -0.07 | -0.67 | -0.68 | -0.9 | |
Capex to revenue | -0.02 | -0.01 | -0.14 | -0.09 | -0.08 | |
Capex to depreciation | -1.23 | -0.37 | -4.36 | -2.65 | -3.04 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.44 | 7.18 | 8.44 | 9.88 | 11.03 | |
ROIC | 0.07 | 0.05 | 0.12 | 0.13 | 0.16 | |
Return on tangible assets | 0.05 | 0.04 | 0.07 | 0.08 | 0.07 | |
Graham Net | -0.96 | -1.19 | -0.79 | -0.8 | -1.15 | |
Working capital | 491.13M | 724.15M | 778.6M | 725.2M | 834M | |
Tangible asset value | 781.63M | 1.36B | 1.49B | 1.73B | 2.04B | |
Net current asset value | 464.71M | 697.34M | 627.45M | 637.38M | 665.58M | |
Invested capital | 0.18 | 0.07 | 0.11 | 0.12 | 0.24 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 150.62M | 209.5M | 273.23M | 314.73M | 363.24M | |
Average inventory | 167.64M | 190.93M | 192.01M | 247.56M | 282.5M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 138.59 | 113.68 | 68.98 | 62.41 | 53.12 | |
Days of inventory on hand | 170.88 | 79.03 | 48.92 | 53.37 | 37.82 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 2.63 | 3.21 | 5.29 | 5.85 | 6.87 | |
Inventory turnover | 2.14 | 4.62 | 7.46 | 6.84 | 9.65 | |
ROE | 0.08 | 0.04 | 0.09 | 0.1 | 0.1 | |
Capex per share | -0.05 | -0.03 | -0.75 | -0.57 | -0.68 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 2.27 | 1.84 | 2.01 | 0 | 2.45 | |
Net income per share | 0.16 | 0.2 | 0.2 | 0 | 0.18 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | -0.13 | -0.15 | -0.18 | 0 | -0.18 | |
Cash per share | 2.66 | 3.82 | 3.63 | 0 | 3.56 | |
Book value per share | 6.64 | 6.78 | 7.04 | 0 | 7.47 | |
Tangible book value per share | 4.63 | 4.78 | 5.05 | 0 | 5.46 | |
Share holders equity per share | 6.64 | 6.78 | 7.04 | 0 | 7.47 | |
Interest debt per share | 1.12 | 2.13 | 1.95 | 0 | 2.15 | |
Market cap | 6.66B | 5.96B | 5.23B | 0 | 5.95B | |
Enterprise value | 6.1B | 5.29B | 4.56B | -620.04M | 5.39B | |
P/E ratio | 26.67 | 19.55 | 16.57 | 0 | 21.29 | |
Price to sales ratio | 7.51 | 8.29 | 6.66 | 0 | 6.25 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | -129.76 | -101.67 | -72.77 | 0 | -83.93 | |
P/B Ratio | 2.57 | 2.25 | 1.9 | 0 | 2.05 | |
PTB ratio | 2.57 | 2.25 | 1.9 | 0 | 2.05 | |
EV to sales | 6.89 | 7.37 | 5.82 | -0.72 | 5.67 | |
Enterprise value over EBITDA | 72.98 | 49.25 | 34.79 | -6.7 | 63.26 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | -119 | -90.34 | -63.55 | 7.85 | -76.1 | |
Earnings yield | 0.01 | 0.01 | 0.02 | 0 | 0.01 | |
Free cash flow yield | -0.01 | -0.01 | -0.01 | 0 | -0.01 | |
Debt to equity | 0.17 | 0.31 | 0.27 | 0.24 | 0.29 | |
Debt to assets | 0.11 | 0.18 | 0.16 | 0.14 | 0.17 | |
Net debt to EBITDA | -6.6 | -6.18 | -5.05 | -6.7 | -6.51 | |
Current ratio | 1.64 | 1.51 | 1.58 | 1.49 | 1.49 | |
Interest coverage | 25.94 | 16.94 | 13.85 | 12.37 | 13.24 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0.01 | 0 | 0 | 0 | |
Payout ratio | 0.06 | 0.46 | 0.23 | 0.1 | 0.07 | |
Sales general and administrative to revenue | 0.02 | 0 | 0.06 | -0.02 | 0.02 | |
Research and developement to revenue | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Intangibles to total assets | 0.19 | 0.17 | 0.17 | 0.17 | 0.16 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | -0.06 | -0.08 | -0.09 | -0.09 | -0.07 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.89 | 5.46 | 5.66 | 0 | 5.5 | |
ROIC | 0.03 | 0.06 | 0.06 | 0.03 | 0.04 | |
Return on tangible assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Graham Net | -0.76 | -0.76 | -0.74 | 0 | -1.1 | |
Working capital | 859.35M | 878.6M | 953.9M | 834M | 883.63M | |
Tangible asset value | 1.81B | 1.86B | 1.97B | 2.04B | 2.12B | |
Net current asset value | 722.35M | 708.03M | 783.44M | 665.58M | 716.25M | |
Invested capital | 0.17 | 0.31 | 0.27 | 0.24 | 0.29 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 285.12M | 317.16M | 363.41M | 368.05M | |
Average inventory | 0 | 258.85M | 235.56M | 256.39M | 290.3M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 31.59 | 46.34 | 49.37 | 47.88 | 37.25 | |
Days of inventory on hand | 32.73 | 36.72 | 34.46 | 34.08 | 32.66 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 2.85 | 1.94 | 1.82 | 1.88 | 2.42 | |
Inventory turnover | 2.75 | 2.45 | 2.61 | 2.64 | 2.76 | |
ROE | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | |
Capex per share | -0.13 | -0.15 | -0.18 | 0 | -0.18 |
300435.SZ Frequently Asked Questions
What is Hangzhou Zhongtai Cryogenic Technology Corporation stock symbol ?
Hangzhou Zhongtai Cryogenic Technology Corporation is a CN stock and trading under the symbol 300435.SZ
What is Hangzhou Zhongtai Cryogenic Technology Corporation stock quote today ?
Hangzhou Zhongtai Cryogenic Technology Corporation stock price is $13.69 today.
Is Hangzhou Zhongtai Cryogenic Technology Corporation stock public?
Yes, Hangzhou Zhongtai Cryogenic Technology Corporation is a publicly traded company.